U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a ...

The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will ...

Sir Keir Starmer and his health secretary have been lauding the potential of the new generation of weight-loss drugs. Given ...

In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...

Prime Minister Keir Starmer said weight-loss drugs like Novo Nordisk’s Ozempic and Eli Lilly and Co’s Mounjaro could help ...

The future of the weight loss market might not revolve around GLP-1 drugs.

Hims & Hers Health shares rose Monday after the Food and Drug Administration said compounding pharmacies could continue to ...

If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal spending ...

Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...